Vaxart, Inc.
Records under this name other than the patents Vaxart, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 3 of 3 · Back to Vaxart, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,906,899 | Bicyclic fused pyrazole derivatives for the treatment of RSV Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,084,796 | Heterocyclic derivatives for the treatment of RSV Formerly held Lapsed on the fee record Ended Aug 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2025 | From the USPTO record |
| US 8,207,373 | Benzoic acid derivatives as human papilloma virus inhibitors Lapsed on the fee record Ended Jun 26, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2020 | From the USPTO record |